Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Kidney Disease Clinical Trials

A listing of Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (464) clinical trials

The primary objective of this study is to: Demonstrate whether, in addition to standard of care (SoC), finerenone is superior to placebo in delaying the progression of kidney disease, as measured by the composite endpoint of time to first occurrence of kidney failure, a sustained decrease of eGFR ≥ 40% ...

Phase

The primary objective of this study is to: Demonstrate whether, in addition to standard of care (SoC), finerenone is superior to placebo in delaying the time to first occurrence of cardiovascular (CV) mortality and morbidity in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease ...

Phase

In this study Retrophin is studying an investigational drug called Sparsentan for treatment of patients with FSGS. The trial is being conducted to collect information about the possible effects of Sparsentan to treat protein loss in patients with FSGS, as well as other positive and negative effects of the medication.

Phase

The purpose of the study is to evaluate whether or not atrasentan is effective in delaying the worsening of kidney disease by comparing the time to serum creatinine doubling or the onset of end stage renal disease in patients with Type 2 diabetes and kidney disease.

Phase

The purpose of the study is to find out if canagliflozin has a kidney and cardiovascular protective effect to reduce the progression of diabetic kidney and heart disease compared to placebo.

Phase

Otsuka Pharmaceuticals is studying an investigational drug called tolvaptan. It is approved in Japan, Canade & England for the treatment of autosomal dominant polycystic kidney disease. When take chronically, tolvaptan seems to slow the rate at which the kidney grows and also seems to slow the rate at which kidney ...

Phase

Demonstrate whether finerenone QD is superior to placebo QD in delaying the time to first occurrence of cardiovascular mortality and morbidity in subjects with T2DM and the clinical diagnosis of DKD. Randomized at 1:1 ratio. Subjects will take one pill once a day.

Phase

The study drug (vadadustat) is an investigational drug. This potential new drug is being tested to treat anemia (low red blood cell count) in patients with chronic (long-term) kidney disease. This is a Phase 3 study, which means that the study drug has already been tested in other studies involving ...

Phase N/A

The study drug (vadadustat) is an investigational drug. This potential new drug is being tested to treat anemia (low red blood cell count) in patients with chronic (long-term) kidney disease. This is a Phase 3 study, which means that the study drug has already been tested in other studies involving ...

Phase N/A